Potential of three-step pretargeting radioimmunotherapy using biotinylated bevacizumab and succinylated streptavidin in triple-negative breast cancer xenograft

Annals of Nuclear Medicine ◽

10.1007/s12149-021-01597-5 ◽

2021 ◽

Author(s):

Wenchao Gu ◽

Ryan Yudistiro ◽

Hirofumi Hanaoka ◽

Natsumi Katsumata ◽

Yoshito Tsushima

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Breast Cancer Xenograft

Download Full-text

PEA-15 Inhibits Tumorigenesis in an MDA-MB-468 Triple-Negative Breast Cancer Xenograft Model through Increased Cytoplasmic Localization of Activated Extracellular Signal-Regulated Kinase

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-09-1456 ◽

2010 ◽

Vol 16 (6) ◽

pp. 1802-1811 ◽

Author(s):

Chandra Bartholomeusz ◽

Ana M. Gonzalez-Angulo ◽

Anna Kazansky ◽

Savitri Krishnamurthy ◽

Ping Liu ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Xenograft Model ◽

Cytoplasmic Localization ◽

Extracellular Signal Regulated Kinase ◽

Breast Cancer Xenograft ◽

Extracellular Signal

Download Full-text

Abstract 1622: In vivo study of dasatinib in combination with veliparib plus carboplatin in triple-negative breast cancer xenograft models

10.1158/1538-7445.am2018-1622 ◽

2018 ◽

Author(s):

Yuliang Sun ◽

Xiaoqian Lin ◽

Jennifer Carlson ◽

Pradip De ◽

Nandini Dey ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

In Vivo Study ◽

Breast Cancer Xenograft ◽

Xenograft Models

Download Full-text

Abstract P5-06-04: The PARP inhibitor niraparib demonstrated activity in patient-derived triple-negative breast cancer xenograft models with high homologous recombination deficiency (HRD) score

10.1158/1538-7445.sabcs14-p5-06-04 ◽

2015 ◽

Author(s):

Yan Wang ◽

Stefano Cairo ◽

Olivier Deas ◽

Anne-Renee Hartman ◽

Joshua Jones ◽

...

Keyword(s):

Breast Cancer ◽

Homologous Recombination ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Parp Inhibitor ◽

Homologous Recombination Deficiency ◽

Breast Cancer Xenograft ◽

Xenograft Models

Download Full-text

Tea Polyphenol Epigallocatechin-3-Gallate Inhibits Cell Proliferation In a Patient-Derived Triple-Negative Breast Cancer Xenograft Mouse Model Via Inhibition of Proline-Dehydrogenase-Induced Effects

Journal of Food and Drug Analysis ◽

10.38212/2224-6614.3230 ◽

2021 ◽

Vol 29 (1) ◽

pp. 113-127

Author(s):

Wen-Jui Lee ◽

Tzu-Chun Cheng ◽

Yun Yen ◽

Chia-Lang Fang ◽

You-Cheng Liao ◽

...

Keyword(s):

Breast Cancer ◽

Cell Proliferation ◽

Mouse Model ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Proline Dehydrogenase ◽

Tea Polyphenol ◽

Xenograft Mouse Model ◽

Breast Cancer Xenograft

Download Full-text

Abstract 2742: The PARP inhibitor niraparib demonstrates robust activity in a subset of patient-derived triple-negative breast cancer xenograft models

10.1158/1538-7445.am2014-2742 ◽

2014 ◽

Author(s):

Yan Wang ◽

Stefano Cairo ◽

Delphine Nicolle ◽

Razvan Cristescu ◽

Andrey Loboda ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Parp Inhibitor ◽

Breast Cancer Xenograft ◽

Xenograft Models

Download Full-text

Abstract P6-08-04: Preclinical efficacy of dasatinib in combination with PARP inhibitor plus standard cytotoxic agent in triple-negative breast cancer xenograft model

10.1158/1538-7445.sabcs16-p6-08-04 ◽

2017 ◽

Author(s):

Y Sun ◽

X Lin ◽

JH Carlson ◽

P De ◽

N Dey ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Parp Inhibitor ◽

Xenograft Model ◽

Cytotoxic Agent ◽

Breast Cancer Xenograft ◽

Preclinical Efficacy

Download Full-text

75 The Aurora A kinase inhibitor MLN8237 in combination with docetaxel induces synergistic antitumor activity in triple-negative breast cancer xenograft models

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)71780-8 ◽

2010 ◽

Vol 8 (7) ◽

pp. 32

Author(s):

M. Zhang ◽

J.J. Huck ◽

M.L. Hyer ◽

K. Kannan ◽

S. Stroud ◽

...

Keyword(s):

Breast Cancer ◽

Antitumor Activity ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Kinase Inhibitor ◽

Aurora A Kinase ◽

Aurora A ◽

Breast Cancer Xenograft ◽

Xenograft Models ◽

Synergistic Antitumor Activity

Download Full-text

Combination Therapy of Capecitabine with Cyclophosphamide as a Second-Line Treatment after Failure of Paclitaxel plus Bevacizumab Treatment in a Human Triple Negative Breast Cancer Xenograft Model

Journal of Cancer Therapy ◽

10.4236/jct.2013.47144 ◽

2013 ◽

Vol 04 (07) ◽

pp. 1236-1241

Author(s):

Mieko Yanagisawa ◽

Keigo Yorozu ◽

Mitsue Kurasawa ◽

Yoichiro Moriya ◽

Naoki Harada

Keyword(s):

Breast Cancer ◽

Combination Therapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Xenograft Model ◽

Line Treatment ◽

Second Line ◽

Breast Cancer Xenograft ◽

Bevacizumab Treatment

Download Full-text

Protein expression profiling of plasma and lungs at different stages of metastatic development in a human triple negative breast cancer xenograft model

PLoS ONE ◽

10.1371/journal.pone.0215909 ◽

2019 ◽

Vol 14 (5) ◽

pp. e0215909 ◽

Author(s):

Maria K. Tveitarås ◽

Frode Selheim ◽

Kristina Sortland ◽

Rolf K. Reed ◽

Linda Stuhr

Keyword(s):

Breast Cancer ◽

Protein Expression ◽

Triple Negative Breast Cancer ◽

Expression Profiling ◽

Triple Negative ◽

Xenograft Model ◽

Breast Cancer Xenograft ◽

Metastatic Development

Download Full-text

Oral administration of penta-O-galloyl- -D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition

Carcinogenesis ◽

10.1093/carcin/bgr015 ◽

2011 ◽

Vol 32 (6) ◽

pp. 804-811 ◽

Author(s):

H.-J. Lee ◽

N.-J. Seo ◽

S.-J. Jeong ◽

Y. Park ◽

D.-B. Jung ◽

...

Keyword(s):

Breast Cancer ◽

Oral Administration ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Strong Association ◽

Breast Cancer Xenograft ◽

Xenograft Growth ◽

Stat3 Inhibition

Download Full-text